These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
67 related articles for article (PubMed ID: 8593176)
21. An approach towards the synthesis of potential metal-chelating TSAO-T derivatives as bidentate inhibitors of human immunodeficiency virus type 1 reverse transcriptase. Chamorro C; Camarasa MJ; Pérez-Pérez MJ; de Clercq E; Balzarini J; San Félix A Antivir Chem Chemother; 1998 Sep; 9(5):413-22. PubMed ID: 9875394 [TBL] [Abstract][Full Text] [Related]
22. Synthesis and antiviral activities of novel acylhydrazone derivatives targeting HIV-1 capsid protein. Tian B; He M; Tang S; Hewlett I; Tan Z; Li J; Jin Y; Yang M Bioorg Med Chem Lett; 2009 Apr; 19(8):2162-7. PubMed ID: 19297155 [TBL] [Abstract][Full Text] [Related]
23. Synthesis and antiviral activity of (Z)- and (E)-2,2-[bis(hydroxymethyl)cyclopropylidene]methylpurines and -pyrimidines: second-generation methylenecyclopropane analogues of nucleosides. Zhou S; Breitenbach JM; Borysko KZ; Drach JC; Kern ER; Gullen E; Cheng YC; Zemlicka J J Med Chem; 2004 Jan; 47(3):566-75. PubMed ID: 14736238 [TBL] [Abstract][Full Text] [Related]
24. Synthesis and anti-tubercular activity of a series of 2-sulfonamido/trifluoromethyl-6-substituted imidazo[2,1-b]-1,3,4-thiadiazole derivatives. Gadad AK; Noolvi MN; Karpoormath RV Bioorg Med Chem; 2004 Nov; 12(21):5651-9. PubMed ID: 15465343 [TBL] [Abstract][Full Text] [Related]
25. [In vitro antimycobacterial activities of a new quinolone, balofloxacin]. Kawahara S; Tada A; Nagare H Kekkaku; 2001 Jan; 76(1):29-31. PubMed ID: 11211780 [TBL] [Abstract][Full Text] [Related]
26. [Frontier of mycobacterium research--host vs. mycobacterium]. Okada M; Shirakawa T Kekkaku; 2005 Sep; 80(9):613-29. PubMed ID: 16245793 [TBL] [Abstract][Full Text] [Related]
27. Novel potential agents for human cytomegalovirus infection: synthesis and antiviral activity evaluation of benzothiadiazine dioxide acyclonucleosides. Martinez A; Esteban AI; Castro A; Gil C; Conde S; Andrei G; Snoeck R; Balzarini J; De Clercq E J Med Chem; 1999 Apr; 42(7):1145-50. PubMed ID: 10197958 [TBL] [Abstract][Full Text] [Related]
28. [Nontuberculous mycobacteriosis; the present status and in the future. 3--(1). The view of development of new drugs against nontuberculous mycobacterial infections]. Kawahara S; Nagare H Kekkaku; 1998 Feb; 73(2):77-82. PubMed ID: 9545700 [TBL] [Abstract][Full Text] [Related]
29. In vitro activity of C-8-methoxy fluoroquinolones against mycobacteria when combined with anti-tuberculosis agents. Lu T; Drlica K J Antimicrob Chemother; 2003 Dec; 52(6):1025-8. PubMed ID: 14613961 [TBL] [Abstract][Full Text] [Related]
30. Synthesis, characterization and antimycobacterial activity of Ag(I)-aspartame, Ag(I)-saccharin and Ag(I)-cyclamate complexes. Cavicchioli M; Leite CQ; Sato DN; Massabni AC Arch Pharm (Weinheim); 2007 Oct; 340(10):538-42. PubMed ID: 17912678 [TBL] [Abstract][Full Text] [Related]
31. Antiretroviral activity of semisynthetic derivatives of glycopeptide antibiotics. Balzarini J; Pannecouque C; De Clercq E; Pavlov AY; Printsevskaya SS; Miroshnikova OV; Reznikova MI; Preobrazhenskaya MN J Med Chem; 2003 Jun; 46(13):2755-64. PubMed ID: 12801238 [TBL] [Abstract][Full Text] [Related]
32. In vitro and ex vivo activity of new derivatives of acetohydroxyacid synthase inhibitors against Mycobacterium tuberculosis and non-tuberculous mycobacteria. Sohn H; Lee KS; Ko YK; Ryu JW; Woo JC; Koo DW; Shin SJ; Ahn SJ; Shin AR; Song CH; Jo EK; Park JK; Kim HJ Int J Antimicrob Agents; 2008 Jun; 31(6):567-71. PubMed ID: 18337064 [TBL] [Abstract][Full Text] [Related]
33. (Z)- and (E)-2-((hydroxymethyl)cyclopropylidene)methyladenine and -guanine. New nucleoside analogues with a broad-spectrum antiviral activity. Qiu YL; Ksebati MB; Ptak RG; Fan BY; Breitenbach JM; Lin JS; Cheng YC; Kern ER; Drach JC; Zemlicka J J Med Chem; 1998 Jan; 41(1):10-23. PubMed ID: 9438017 [TBL] [Abstract][Full Text] [Related]
34. Antimycobacterial and antifungal isosters of salicylamides. Waisser K; Pesina M; Holý P; Pour M; Bures O; Kunes J; Klimesová V; Buchta V; Kubanová P; Kaustová J Arch Pharm (Weinheim); 2003 Aug; 336(6-7):322-35. PubMed ID: 12953220 [TBL] [Abstract][Full Text] [Related]
36. [Studies on synthesis and anti-HIV RT activity of hypericin and ethylhypericin]. Zhao J; Zhang Z; Chen H; Chen X Yao Xue Xue Bao; 1998; 33(1):67-71. PubMed ID: 11938940 [TBL] [Abstract][Full Text] [Related]
37. Identification of antibacterial and antiviral activities of novel fused 1,2,4-triazine esters. Sztanke K; Pasternak K; Rajtar B; Sztanke M; Majek M; Polz-Dacewicz M Bioorg Med Chem; 2007 Aug; 15(16):5480-6. PubMed ID: 17572093 [TBL] [Abstract][Full Text] [Related]
38. Synthesis and in vitro antimycobacterial activity of novel 3-(1H-pyrrol-1-yl)-2-oxazolidinone analogues of PNU-100480. Sbardella G; Mai A; Artico M; Loddo R; Setzu MG; La Colla P Bioorg Med Chem Lett; 2004 Mar; 14(6):1537-41. PubMed ID: 15006398 [TBL] [Abstract][Full Text] [Related]
39. Synthesis and anti-HIV activity of 10,11-dihydropyrrolo [1,2-b][1,2,5]benzothiadiazepine-11-acetic acid 5,5-dioxide derivatives and related compounds. Silvestri R; Artico M; Pagnozzi E; Stefancich G; Massa S; La Colla P; Loi AG; Spiga MG; Corrias S; Lichino D Farmaco; 1996 Jun; 51(6):425-30. PubMed ID: 8766226 [TBL] [Abstract][Full Text] [Related]
40. Antimycobacterial activity of 3'- and 4'-fluorothiobenzanilides. Waisser K; Kunes J; Odlerová Z; Roman M; Kubicová L; Horák V Pharmazie; 1998 Mar; 53(3):193-5. PubMed ID: 9547521 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]